Related Experiment Video
Updated: Aug 15, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
JANUS under stress--role of JAK/STAT signaling pathway in vascular diseases
Karsten Grote1, Maren Luchtefeld, Bernhard Schieffer
1Department of Cardiology and Angiology, Medizinische Hochschule Hannover, 30625 Hannover, Germany.
Abstract:
They were more than just another kinases (JAK), when they were first described in the late 80s and named JAK kinases. The mandatory role of this novel family of dual active janus kinases (JAK) and their substrates the signal transducers and activators of transcription (STAT) was demonstrated in mice who died during embryogenesis when lacking a functional allele, e.g. that of JAK2. Initially, the JAK/STAT signaling pathway was discovered as the primary mediator of intracellular signaling induced by interferon in hematopoietic and immune cells. Nowadays, it is well accepted that JAK kinases and STAT proteins are constitutively expressed in the vessel wall in a cell type specific manner and transfer intracellular signaling events of various receptor families, e.g. that of cytokines, growth factors and vasoactive peptides such as angiotensin II (Ang II) or endothelin. The potential impact of the JAK/STAT signaling pathway on cardiovascular pathophysiology and disease development arise from reports describing that JAKs may bind directly to the angiotensin II type I (AT(1)) receptor, thereby enhancing their phosphorylation in various cell types of the vessel wall. More interestingly, these signaling events are modulated by NAD(P)H oxidase-derived superoxide anions which directly phosphorylate JAK2 and thereby control JAK2 activity. A potential impact was also described for atherosclerotic plaque development in which the activation of JAKs and STATs seems to be critical. Based on these observations, we here review the role of the JAK/STAT signaling pathways as critical regulator for cardiovascular disease development, i.e. atherosclerotic plaque progression or the manifestation of arterial hypertension.
Insights
The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is crucial in cardiovascular health. Dysregulation of this pathway contributes to diseases like atherosclerosis and hypertension.
Area of Science:
- Cardiovascular Biology
- Molecular Signaling
- Immunology
Background:
- The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway, initially identified in immune cells, is now recognized for its role in the cardiovascular system.
- JAKs and STATs are expressed in the vessel wall, mediating signals from cytokines, growth factors, and vasoactive peptides like angiotensin II.
- The JAK/STAT pathway's involvement in cardiovascular pathophysiology is suggested by JAKs binding to the angiotensin II type I receptor and modulation by NAD(P)H oxidase.
Purpose of the Study:
- To review the critical role of the JAK/STAT signaling pathway in cardiovascular disease development.
- To explore the pathway's involvement in atherosclerotic plaque progression and arterial hypertension.
Main Methods:
- Review of existing literature on JAK/STAT signaling in cardiovascular research.
- Analysis of studies investigating JAK-receptor interactions and modulation by reactive oxygen species.
- Examination of evidence linking JAK/STAT activation to cardiovascular pathologies.
Main Results:
- JAK/STAT signaling is constitutively expressed in the vessel wall and participates in diverse receptor-mediated signaling.
- JAKs can directly interact with the angiotensin II type I receptor, influencing cardiovascular responses.
- NAD(P)H oxidase-derived superoxide anions modulate JAK2 activity, impacting signaling pathways.
- Activation of JAKs and STATs appears critical for atherosclerotic plaque development.
Conclusions:
- The JAK/STAT signaling pathway is a significant regulator of cardiovascular disease progression.
- Understanding JAK/STAT signaling mechanisms is vital for developing therapeutic strategies against atherosclerosis and hypertension.
Related Concept Videos
The JAK-STAT Signaling Pathway
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Nitric Oxide Signaling Pathway
Non-Canonical Wnt Signaling Pathways